We are live on ! Find out more
LLY icon

Eli Lilly

1,117 hedge funds and large institutions have $61B invested in Eli Lilly in 2015 Q1 according to their latest regulatory filings, with 76 funds opening new positions, 378 increasing their positions, 463 reducing their positions, and 75 closing their positions.

New
Increased
Maintained
Reduced
Closed

75% more call options, than puts

Call options by funds: $458M | Put options by funds: $261M

23% more funds holding in top 10

Funds holding in top 10: 3543 (+8)

5% more capital invested

Capital invested by funds: $58B → $61B (+$3.09B)

1% more first-time investments, than exits

New positions opened: 76 | Existing positions closed: 75

0.13% more ownership

Funds ownership: 75.64%75.78% (+0.13%)

1% less funds holding

Funds holding: 1,1291,117 (-12)

18% less repeat investments, than reductions

Existing positions increased: 378 | Existing positions reduced: 463

Holders
1,117
Holders Change
-12
Holders Change %
-1.06%
% of All Funds
29.76%
Holding in Top 10
43
Holding in Top 10 Change
+8
Holding in Top 10 Change %
+22.86%
% of All Funds
1.15%
New
76
Increased
378
Reduced
463
Closed
75
Calls
$458M
Puts
$261M
Net Calls
+$197M
Net Calls Change
+$332M
Name Holding Trade Value Shares
Change
Change in
Stake
USAA
151
United Services Automobile Association
Texas
$32.6M -$741K -10,409 -2%
SCM
152
SKBA Capital Management
California
$32.6M -$242K -3,400 -0.8%
AIM
153
abrdn Investment Management
United Kingdom
$32.6M +$6.58M +92,391 +26%
Millennium Management
154
Millennium Management
New York
$32.4M -$1.86M -26,101 -6%
Calamos Advisors
155
Calamos Advisors
Illinois
$32M +$638K +8,958 +2%
BA
156
Boston Advisors
Massachusetts
$31.4M +$897K +12,598 +3%
Caisse de Depot et Placement du Quebec (CDPQ)
157
Caisse de Depot et Placement du Quebec (CDPQ)
Quebec, Canada
$31.4M -$3.12M -43,800 -9%
D.E. Shaw & Co
158
D.E. Shaw & Co
New York
$31.1M -$27.7M -389,075 -48%
SDIC
159
South Dakota Investment Council
South Dakota
$30.9M -$3.64M -51,180 -11%
SCP
160
Seizert Capital Partners
Michigan
$30.7M -$17.1M -240,331 -36%
BCIM
161
British Columbia Investment Management
British Columbia, Canada
$30.5M -$2.52M -35,398 -8%
Renaissance Technologies
162
Renaissance Technologies
New York
$30.4M -$28.8M -404,395 -49%
JMPWA
163
JP Morgan Private Wealth Advisors
California
$30M +$72.1K +1,013 +0.2%
Macquarie Group
164
Macquarie Group
Australia
$29.8M -$11.3M -159,300 -28%
MME
165
Meag Munich Ergo
Germany
$29M
Korea Investment Corp
166
Korea Investment Corp
South Korea
$28.8M +$4.49M +63,000 +19%
Voloridge Investment Management
167
Voloridge Investment Management
Florida
$28.3M +$26.1M +366,640 +1,628%
SOMRS
168
State of Michigan Retirement System
Michigan
$27.4M -$1.88M -26,400 -7%
ZIM
169
Zacks Investment Management
Illinois
$27.3M +$1.05M +14,724 +4%
CI
170
Conning Inc
Connecticut
$27.3M +$4.59M +64,492 +21%
AIG
171
American International Group
New York
$26.9M -$9.12M -128,082 -26%
AG
172
Aperio Group
California
$26.8M +$3.71M +52,107 +16%
BM
173
Bridger Management
New York
$26.7M +$26.1M +366,893 New
TPSF
174
Texas Permanent School Fund
Texas
$26.6M -$465K -6,530 -2%
Tudor Investment Corp
175
Tudor Investment Corp
Connecticut
$26.1M +$10.5M +148,100 +70%

LLY Hedge Fund Activity: Q1 2015 in Review

1,117 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Eli Lilly (LLY) for Q1 2015, worth a combined $61B — up 5.3% from $58B a quarter earlier.

Buyers outnumbered sellers: 76 funds opened new LLY positions and 75 closed out — a net gain of 1 holder — while 378 added to existing stakes and 463 trimmed.

The largest buyer was Janus Henderson Investors US, adding an estimated $352M. The largest seller was T. Rowe Price Associates, cutting an estimated $254M.

  • 1,117 institutional investors held Eli Lilly (LLY) as of Q1 2015, down from 1,129 in Q4 2014.
  • Funds reported $61B of Eli Lilly stock for Q1 2015, up 5.3% quarter-over-quarter.
  • 76 funds opened new Eli Lilly positions in Q1 2015 and 75 closed out, a net change of +1 holder.
  • The largest Eli Lilly buyer in Q1 2015 was Janus Henderson Investors US, an estimated $352M added.
  • The largest Eli Lilly seller in Q1 2015 was T. Rowe Price Associates, an estimated $254M sold.

Based on aggregated 13F filings for Q1 2015.